Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Latest filing published 24 Aug 2026 for Starling Oncology, Inc., €1.7M. Read the official filing
Filing timeline
BuySaleBrad Hively
Insider track record
Disclosed buys
2
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brad Hively: trading record in brief
All filings by Brad Hively on record concern Starling Oncology, Inc., in the capacity of chief executive. We count 23 filings; the first trade dates from 12 January 2021 and the latest from 21 August 2026.
Both buying and selling appear: 2 purchases worth €52k, against 4 sales worth €1.8M. Netting one side against the other leaves €1.7M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 9 share grants and 3 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 24 August 2026: an open-market sale of €1.7M, in Starling Oncology, Inc. The last purchase on record was published on 28 April 2025, which is 538 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brad Hively
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
298,853 shares@ US$6.51260.29% mcap100.0% of flowCommon StockSEC:0001079973-26-001175:0
27,108 shares0Common StockSEC:0001079973-26-000983:0
13,333 shares@ US$3.77195.1% of flowCommon StockSEC:0001079973-25-001861:0
41,667 shares0Common StockSEC:0001553350-25-000143:0
20,221 shares@ US$4.068.8% of flowCommon stockSEC:0000935836-25-000552:0
684,528 shares@ US$0.8570.1% of flowCommon StockSEC:0000935836-25-000416:0
45,280 shares@ US$1.041720.1% of flowCommon StockSEC:0000935836-25-000296:0
Canonical exit: 24 Jun 2025 (T+90)
9,056 shares@ US$1.04174.0% of flowCommon StockSEC:0001079973-25-000521:0
Canonical exit: 24 Jun 2025 (T+90)
353,450 shares0Common stockSEC:0001799191-24-000063:0
44,000 shares0Common stockSEC:0001799191-24-000050:0
18,121 shares@ US$0.45783.6% of flowCommon StockSEC:0001799191-24-000015:0
19,526 shares@ US$0.57534.8% of flowCommon StockSEC:0001799191-24-000013:0
42,652 shares0Common stockSEC:0001628280-23-042829:0
25,867 shares@ US$2.19323.8% of flowCommon stockSEC:0001628280-23-039913:0
25,000 shares@ US$0.859.0% of flowCommon stockSEC:0001628280-23-039815:0
47,000 shares@ US$0.8517.2% of flowCommon stockSEC:0001628280-23-039192:0
168,512 shares0Common stockSEC:0001628280-23-008825:0
9,718 shares@ US$2.02788.8% of flowCommon StockSEC:0001799191-22-000050:0
103,469 shares0Common StockSEC:0001799191-22-000032:0
9,718 shares@ US$2.02788.8% of flowCommon StockSEC:0001799191-22-000012:0
108,469 shares0Common stockSEC:0001628280-22-007101:0
141,380 shares0Common StockSEC:0001104659-21-141460:0
141,380 shares0Common StockSEC:0001104659-21-140219:0
23 of 23 declarations
